GLOBAL NON OPIOID PAIN TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
Global Non Opioid Pain Treatment Market, By Drug Type (Non-Steroidal Anti-Inflammatory Drugs, Steriods, Analgesics, Corticosteroids, Others), By Indication (Musco Skeletal Disorders, Central Nervous System Disorders, Traumatic Pain, Chronic Pain, Others), By Route of Administration (Topical, Intravenous, Oral), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
On February 05, 2024, Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, announced the launch of COMBOGESIC IV (acetaminophen and ibuprofen) injection in the U.S. COMBOGESIC IV is an intravenous, opioid-free pain reliever that contains 1,000 mg of acetaminophen and 300 mg of ibuprofen, a nonsteroidal anti-inflammatory drug.
In December 2023, Vertex Pharmaceuticals, a pharmaceutical company, announced that a non-opioid painkiller significantly reduced pain in diabetic patients suffering from chronic nerve pain in a mid-stage trial, fueling efforts to develop a medication free of the risk of addiction. The research looked at the medicine VX-548 in individuals who had diabetic peripheral neuropathy, a kind of nerve damage caused by high blood sugar.
In October 2023, Hyloris Pharmaceuticals, a Belgium based pharmaceutical company, announced the approval of a potent non-opioid painkiller in the U.S. Maxigesic IV's New Drug Application (NDA) had been authorized by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate pain and as an additional therapy for moderate to severe pain
In February 2020, GlaxoSmithKline, a pharmaceutical company, announced that the US FDA has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)-arthritis pain reliever) as an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle, or knee in adults (18 years and older).
Global Non Opioid Pain Treatment Market Report Snapshots